Awareness of the diagnosis, treatment, and control of diabetes mellitus in Brazil.

Autor:	Tonaco LAB; Universidade Federal de Minas Gerais . Escola de Enfermagem . Departamento de Enfermagem Materno Infantil e Saúde Pública . Belo Horizonte , MG , Brasil., Velasquez-Melendez G; Universidade Federal de Minas Gerais . Escola de Enfermagem . Departamento de Enfermagem Materno Infantil e Saúde Pública . Belo Horizonte , MG , Brasil., Moreira AD; Universidade Federal de Minas Gerais . Escola de Enfermagem . Departamento de Enfermagem Materno Infantil e Saúde Pública . Belo Horizonte , MG , Brasil., Andrade FCD; University of Illinois . School of Social Work . Urbana-Champaign , United States., Malta DC; Universidade Federal de Minas Gerais . Escola de Enfermagem . Departamento de Enfermagem Materno Infantil e Saúde Pública . Belo Horizonte , MG , Brasil., Felisbino-Mendes MS; Universidade Federal de Minas Gerais . Escola de Enfermagem . Departamento de Enfermagem Materno Infantil e Saúde Pública . Belo Horizonte , MG , Brasil.
Jazyk:	English; Portuguese
Zdroj:	Revista de saude publica [Rev Saude Publica] 2023 Nov 03; Vol. 57, pp. 75. Date of Electronic Publication: 2023 Nov 03 (Print Publication: 2023).
DOI:	10.11606/s1518-8787.2023057005167
Abstrakt:	Objective: To estimate the proportions of awareness, treatment, and control of diabetes mellitus (DM) in the Brazilian adult population. Method: This is a cross-sectional study, with data from a representative sample of the Brazilian population, taken from the National Health Survey(PNS 2014/2015). Outcomes were defined based on glycated hemoglobin (HbA1c) measurements, self-reported DM diagnosis, and use of hypoglycemic agents or insulin. The proportion of DM awareness, treatment, and control was estimated according to sociodemographic characteristics, health conditions, and access to health services, and their respective 95% confidence intervals. Results: DM prevalence in the Brazilian population was of 8.6% (95%CI: 7.8-9.3): 68.2% (95%CI: 63.9-72.3) were aware of their diagnosis, 92.2% (95%CI: 88.6-94.7) of those who were aware were undergoing drug treatments, and, of these, 35.8% (95%CI: 30.5-41.6) had controlled HbA1c levels. The proportions of DM awareness, control, and treatment were lower in men aged 18 to 39 years, individuals with low education, without health insurance, and beneficiaries of the Bolsa Família program. Conclusion: Approximately one in ten Brazilians has DM. A little more than half of this population is aware of their diagnosis, a condition measured by HbA1c dosage and clinical diagnosis. Among those who know, the vast majority are undergoing drug treatments. However, less than half of these have their HbA1c levels controlled. Worse scenarios were found in subgroups with high social vulnerability.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu